Posted by Site Administrator on May 29, 2012
Stevens thinks that their findings might shed light on diseases that involve synapse loss or dysfunction. In neurodegenerative diseases such as glaucoma, Alzheimer’s disease, Lou Gehrig’s disease (ALS), Huntington’s disease and Parkinson’s disease, scientists have noted subtle changes in synapses that might cause them to be targeted for elimination.
Categories: Research News
|
Tags: 501(c)(3) ALS charity, ALS, ALS Awareness Month, ALS community, ALS research, ALS synapses, amyotrophic lateral sclerosis, Beth Stevens PhD, Bob Stehlin, Boston Children's Hospital, Dori Schafer PhD, he journal Neuron, immune cells, Kirby Neurobiology Center at Boston Children's Hospital, Lou Gehrig's disease, microglia, microglia receptors, neurodegenerative diseases, protein C3, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis
|
No comments